News

Jazz Pharmaceuticals (NASDAQ: JAZZ) has announced that the US Food and Drug Administration (FDA) has granted marketing approval for Defitelio (defibrotide sodium) for the treatment of adult and paediatric patients with hepatic veno-occlusive disease. Also called sinusoidal obstruction syndrome (SOS), Defitelio is indicated for the treatment of t...

Science Foundation Ireland is seeking to fund researchers who are at the initial stages of developing a new or innovative technology, product, process or service with strong commercial potential. For researchers who wish to pursue the commercialisation of a technology, TIDA provides: Technical validation by independent international peer review ...

Praluent is a proproetin convertase subtilisin/kexin type 9 (or PCSK9) inhibitor that is being evaluated as a treatment in patients with an inherited form of high cholesterol known as heterozygous familial hypercholesterolemia (HeFH). With HeFH, cholesterol levels require chronic, weekly or bi-weekly apheresis therapy, which is a therapy where b...

Sanders asks Treasury to 'block' Pfizer and Allergan merger By Eric Palmer Sen. Bernie Sanders In between campaign stops, presidential candidate Sen. Bernie Sanders is finding time to keep pressure on the pharmaceutical industry. This time he is pushing the U.S. Treasury Department to try to stop Pfizer's ($PFE) $160 billion tax-avoiding merger ...

Doctors taking a shine to biosimilars as they get experience with them March 18, 2016 | By Eric Palmer Three years ago, doctors in Europe displayed grave doubts about using biosimilars instead of branded biologics on their patients. But after a couple of years of experience with a biosimilar of Merck's ($MRK) Remicade (infliximab) from Hospira a...

NEW U.S.-IRELAND R&D PARTNERSHIP PROJECT TO RESEARCH CONTINUOUS MANUFACTURING FOR NANO-BASED PHARMACEUTICAL DRUGS WASHINGTON, U.S., 18th March 2016: A tripartite US-Ireland R&D partnership was announced at an event hosted in Washington D.C. by Science Foundation Ireland to celebrate scientific collaboration between Ireland and the United States....

Sanofi ($SNY) and Regeneron ($REGN), awaiting FDA approval for a potential blockbuster rheumatoid arthritis treatment, burnished the drug's profile with Phase III data showing it beat AbbVie's ($ABBV) top-selling Humira head to head. The treatment, sarilumab, is an antibody targeting the inflammation-related protein interleukin-6 to treat autoim...

Ireland is building a reputation as a world leader in scientific research capability, continuously climbing the international citation and innovation rankings to be in the top 20 countries overall for citations, while achieving rankings of 2nd , 3rd and 5th in Nanoscience, Materials Science and Computer Science research respectively. Ireland is ...